Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...

1. Clinical Practice Guidelines Group. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126(Suppl):1S 92S This statement ...

Looking for reliable medications to treat 'Pulmonary Hypertension'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Considering taking supplements to treat pulmonary hypertension? Below is a list of common natural remedies used to treat or reduce the symptoms of pulmonary hypertension. Follow the links to read ...

In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...

Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.

Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...

Keros Therapeutics has halted the dosing of its treatment for pulmonary hypertension due to adverse health effects discovered during trials. The clinical-stage biopharmaceutical company said ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

Professor Christopher Denton discusses key aspects of the 2024 British Society for Rheumatology guideline on managing systemic sclerosis.

To Know in detail about the Chronic Pulmonary Hypertension market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Pulmonary Hypertension Market Forecast Some ...